Hepatitis C New D...
Follow
Find
11.1K views | +0 today
Hepatitis C New Drugs Review
FDA approved Incivek(telaprevir, Vertex) on Monday 23 May by its PDUFA deadline.A paradigm shift in the treatment of Hepatitis C virus infection. http://knol.google.com/k/krishan-maggon/boceprevir-merck-telaprevir-vertex/3fy5eowy8suq3/151#
Curated by Krishan Maggon
Your new post is loading...
Your new post is loading...
Scooped by Krishan Maggon
Scoop.it!

Scripps Research Institute Scientists Achieve Most Detailed Picture Ever of Key Part of Hepatitis C Virus

Scripps Research Institute Scientists Achieve Most Detailed Picture Ever of Key Part of Hepatitis C Virus | Hepatitis C New Drugs Review | Scoop.it
News Release
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Simeprevir, New Treatment for Hepatitis C Approved by Health Canada Priority Review Gives Physicians and Patients an Effective and Tolerable Treatment Choice

Simeprevir, New Treatment for Hepatitis C Approved by Health Canada. Now let's hope it will be covered soon! http://t.co/kEZkjZdUEk
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

HCV New Drug Research: Effect of fibrosis on adverse events in ...

Effect of fibrosis on adverse events in patients with hepatitis C treated with telaprevir. A study published ahead of print the Alimentary Pharmacology & Therapeutics investigates adverse events of telaprevir-based therapy in ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Gilead Sciences, Inc. (GILD): New Hepatitis C Drug Success Should Drive ...

Gilead Sciences, Inc. (GILD): New Hepatitis C Drug Success Should Drive ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Boehringer Ingelheim Hep C Drug Gets Accelerated Assessment from EMA

Drug Discovery & Development Boehringer Ingelheim Hep C Drug Gets Accelerated Assessment from EMA Drug Discovery & Development The application for European marketing authorization of faldaprevir, a potent second generation oral protease inhibitor,...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Gilead stock hits record after hepatitis C drug's success in Europe

Gilead Sciences said Friday that an advisory committee in the European Union is recommending that its hepatitis C drug Sovaldi receive marketing approval.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

FDA approves Olysio (simeprevir, J&J) a new treatment for hepatitis C virus.

The U.S. Food and Drug Administration today approved Olysio (simeprevir), a new therapy to treat chronic hepatitis C virus infection.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

The Next Wave of Agents for Treatment of Hepatitis C

The Next Wave of Agents for Treatment of Hepatitis C Medscape A few years ago, the US Food and Drug Administration (FDA) approved 2 direct-acting antiviral agents for the treatment of HCV genotype 1: the NS3 protease inhibitors telaprevir and...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

GALEXOS™ (simeprevir,J&J) for Hepatitis C Approved by Health Canada Priority Review

New Treatment for Hepatitis C Approved by Health Canada Priority Review ...
Canada NewsWire (press release)
TORONTO, Nov. 20, 2013 /CNW/ - Janssen Inc.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

AbbVie All-Oral, Interferon-Free, 12-week Regimen, Showing 96 Percent SVR12 in Genotype 1 Hepatitis C Patients

For members of the media and job seekers, this page provides easy access to AbbVie media and press contacts via various channels.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Can Vertex Survive Post-Incivek?

Gilead Sciences and Johnson & Johnson are about to launch new oral hepatitis C treatments that will significantly reduce Vertex sales from Incivek. The.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort - Backus - 2013 - Alimentary Pharmacology & Therapeutics - Wiley Online Library

RT @wuefab: Comparative effectiveness of #HCV protease inhibitors: #telaprevir > #boceprevir in a large US cohort. http://t.co/NuLtReF1Eu v…
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Gilead Sciences, Inc. (GILD): Gilead Vs. Challengers In The Hepatitis C Race - Seeking Alpha

Gilead Sciences, Inc. (GILD): Gilead Vs.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Detection of hepatitis C virus (HCV)

Although hepatitis C virus (HCV) is primarily hepatotropic, markers of HCV replication were detected in peripheral blood mononuclear cells (PBMC) as well as in ex vivo collected tissues and organs. Specific strains of HCV ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Boehringer's faldaprevir set for rapid review in Europe - PMLiVE

Boehringer's faldaprevir set for rapid review in Europe PMLiVE If approved, faldaprevir will compete with current HCV protease inhibitors - namely Merck & Co's Victrelis (boceprevir) and Vertex/Johnson & Johnson's Incivo/Incivek (telaprevir) - that...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Chance of approval for Enanta's hep C drug increases with recent data

Chance of approval for Enanta's hep C drug increases with recent data Boston Business Journal (blog) In its first full-year financial report since becoming a publicly-traded biotech, Enanta Pharmaceuticals reported a smaller loss than expected, and...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

The Next Wave of Agents for Treatment of Hepatitis C ~ HCV Research and News

The Next Wave of Agents for Treatment of #Hepatitis C - http://t.co/wTdiuO7v2H #HepC #HCV
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner - Fletcher - Hepatology - Wiley Online Library

Activated macrophages promote hepatitis C virus entry in a tumor necrosis factordependent manner http://t.co/IlVDsqbAql
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of Hepatitis C.

OLYSIO™ (simeprevir) Receives FDA Approval for Combination Treatment of ...
PR Newswire (press release)
OLYSIO™ may benefit patients with chronic hepatitis C, including those who are treatment naive or who have failed prior interferon-based therapy.
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

European CHMP Positive Opinion for Gilead Sovaldi® for Chronic Hepatitis C Infection

more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Vertex Sells INCIVO ® Product Royalty Rights for $152 Million

more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Don't Crown the Hepatitis C Drug Winner Just Yet

Don't Crown the Hepatitis C Drug Winner Just Yet DailyFinance Vertex Pharmaceuticals' Incivek, the first-generation oral drug that has to be combined with Pegasys, grabbed some of those treatment-experienced patients -- that's part of the reason...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

AbbVie reports phase III results from Hepatitis C virus program

BRIEF-AbbVie reports phase III results from Hepatitis C virus program Reuters Nov 18 (Reuters) - AbbVie Inc : * Releases first of six phase III results from investigational all-oral, interferon-free, 12-week regimen, showing 96 percent SVR12 in...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

FDA Hepatitis Update - Changes to Incivek (telaprevir) product ...

FDA approved changes to the Incivek (telaprevir) product labeling to include results from trial C211 (OPTIMIZE) to support a twice daily dosing regimen. In addition new contraindications were added for anticonvulsant ...
more...
No comment yet.
Scooped by Krishan Maggon
Scoop.it!

Bristol not interested in diabetes, hepatitis C treatment any longer

MedCity News Bristol not interested in diabetes, hepatitis C treatment any longer MedCity News Bristol said on Thursday it would no longer conduct research to discover new drugs for diabetes, hepatitis C and neuroscience, but will increase spending...
more...
No comment yet.